Published in Exp Eye Res on July 01, 2009
Mechanisms and management of retinopathy of prematurity. N Engl J Med (2012) 3.52
CD34 Promotes Pathological Epi-Retinal Neovascularization in a Mouse Model of Oxygen-Induced Retinopathy. PLoS One (2016) 1.40
Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog. Invest Ophthalmol Vis Sci (2011) 1.33
Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2013) 1.23
Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology (2014) 1.11
VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression. Am J Pathol (2012) 1.02
VEGFA activates erythropoietin receptor and enhances VEGFR2-mediated pathological angiogenesis. Am J Pathol (2014) 0.99
The role of RPE cell-associated VEGF₁₈₉ in choroidal endothelial cell transmigration across the RPE. Invest Ophthalmol Vis Sci (2011) 0.99
Studies on the pathogenesis of avascular retina and neovascularization into the vitreous in peripheral severe retinopathy of prematurity (an american ophthalmological society thesis). Trans Am Ophthalmol Soc (2010) 0.99
Increased angiogenic factors associated with peripheral avascular retina and intravitreous neovascularization: a model of retinopathy of prematurity. Arch Ophthalmol (2010) 0.98
Endothelial NADPH oxidase 4 mediates vascular endothelial growth factor receptor 2-induced intravitreal neovascularization in a rat model of retinopathy of prematurity. Mol Vis (2014) 0.97
Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity. Arch Ophthalmol (2010) 0.89
Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy. J Histochem Cytochem (2012) 0.87
Loss of MLK3 signaling impedes ulcer healing by modulating MAPK signaling in mouse intestinal mucosa. Am J Physiol Gastrointest Liver Physiol (2012) 0.87
Vascular endothelial growth factor antagonist therapy for retinopathy of prematurity. Clin Perinatol (2014) 0.80
Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity. Mol Vis (2011) 0.79
Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration. Eye Brain (2011) 0.76
Lutein facilitates physiological revascularization in a mouse model of retinopathy of prematurity. Clin Experiment Ophthalmol (2016) 0.75
Promoting vascular repair in the retina: can stem/progenitor cells help? Eye Brain (2016) 0.75
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature (1996) 18.47
Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol (2003) 14.41
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol (2003) 12.96
Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci (1995) 4.97
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet (2001) 4.66
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res (1999) 4.23
Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol (2007) 3.93
Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol Cell Physiol (2001) 3.84
Retinopathy of prematurity. Angiogenesis (2007) 3.20
Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics (2003) 2.89
Mechanisms of integrin-vascular endothelial growth factor receptor cross-activation in angiogenesis. Circ Res (2007) 2.74
Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A (1996) 2.67
Disoriented pathfinding by pioneer neurone growth cones deprived of filopodia by cytochalasin treatment. Nature (1986) 2.57
Filopodia: the fingers that do the walking. Sci STKE (2007) 2.43
Transcutaneous oxygen levels in retinopathy of prematurity. Lancet (1995) 1.89
Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Pediatr Res (1994) 1.88
Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J Biol Chem (2000) 1.83
Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. Traffic (2006) 1.78
The effect of oxygen on vasoformative cell division. Evidence that 'physiological hypoxia' is the stimulus for normal retinal vasculogenesis. Invest Ophthalmol Vis Sci (1995) 1.73
Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation. J Theor Biol (2007) 1.60
Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol (2008) 1.59
Sequential roles for myosin-X in BMP6-dependent filopodial extension, migration, and activation of BMP receptors. J Cell Biol (2007) 1.54
Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity. J Clin Invest (2003) 1.50
Glial, vascular, and neuronal cytogenesis in whole-mounted cat retina. Microsc Res Tech (1997) 1.46
Nonvascular role for VEGF: VEGFR-1, 2 activity is critical for neural retinal development. FASEB J (2001) 1.44
Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol (2007) 1.44
Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging (2007) 1.37
Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes (1995) 1.35
Neutralizing antibody to VEGF reduces intravitreous neovascularization and may not interfere with ongoing intraretinal vascularization in a rat model of retinopathy of prematurity. Mol Vis (2008) 1.29
Localization of VEGF receptor-2 (KDR/Flk-1) and effects of blocking it in oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2002) 1.15
Vascular endothelial growth factor receptors: molecular mechanisms of activation and therapeutic potentials. Exp Eye Res (2006) 1.14
Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci (1998) 1.12
Lamellipodia nucleation by filopodia depends on integrin occupancy and downstream Rac1 signaling. Exp Cell Res (2007) 1.12
Besides adhesion: new perspectives of integrin functions in angiogenesis. Cardiovasc Res (2008) 1.06
The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat. Curr Eye Res (1996) 1.05
Specific involvement of SRC family kinase activation in the pathogenesis of retinal neovascularization. Invest Ophthalmol Vis Sci (2006) 1.04
Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2006) 1.03
Neonatal hypoxic preconditioning involves vascular endothelial growth factor. Neurobiol Dis (2007) 1.01
Neovascularization grading methods in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2000) 0.97
Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase. Jpn J Ophthalmol (2008) 0.96
Therapeutic antibodies targeting angiomotin inhibit angiogenesis in vivo. FASEB J (2007) 0.90
Distribution, metabolism, and excretion of the anti-angiogenic compound SU5416. Toxicol In Vitro (2006) 0.88
Vascular endothelial growth factor (VEGF) inhibition by small molecules. J Chemother (2004) 0.86
Semaxinib (SU5416) as a therapeutic agent targeting oncogenic Kit mutants resistant to imatinib mesylate. Oncogene (2006) 0.84
Indirect relation between rises in oxygen consumption and left ventricular output at birth in lambs. Circ Res (1992) 0.82
CCR3 is a target for age-related macular degeneration diagnosis and therapy. Nature (2009) 2.39
Bone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogenesis in vivo in a mouse model of oxygen-induced retinopathy. Arterioscler Thromb Vasc Biol (2011) 1.56
VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis (2004) 1.40
Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model. Invest Ophthalmol Vis Sci (2008) 1.28
Inhibition of NAD(P)H oxidase reduces apoptosis and avascular retina in an animal model of retinopathy of prematurity. Mol Vis (2007) 1.24
The Photographic Screening for Retinopathy of Prematurity Study (Photo-ROP): study design and baseline characteristics of enrolled patients. Retina (2006) 1.18
Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest Ophthalmol Vis Sci (2008) 1.10
Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10. Ophthalmology (2011) 1.09
The role of vascular endothelial growth factor-induced activation of NADPH oxidase in choroidal endothelial cells and choroidal neovascularization. Am J Pathol (2010) 1.06
Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci (2006) 1.03
VEGF-mediated STAT3 activation inhibits retinal vascularization by down-regulating local erythropoietin expression. Am J Pathol (2012) 1.02
Heterotypic RPE-choroidal endothelial cell contact increases choroidal endothelial cell transmigration via PI 3-kinase and Rac1. Exp Eye Res (2006) 1.02
The role of RPE cell-associated VEGF₁₈₉ in choroidal endothelial cell transmigration across the RPE. Invest Ophthalmol Vis Sci (2011) 0.99
Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity. Am J Pathol (2013) 0.94
Determining fungi rRNA copy number by PCR. J Biomol Tech (2013) 0.88
Real-time, computer-assisted quantification of plus disease in retinopathy of prematurity at the bedside. Ophthalmic Surg Lasers Imaging Retina (2014) 0.86
Signaling pathways triggered by oxidative stress that mediate features of severe retinopathy of prematurity. JAMA Ophthalmol (2013) 0.83
Exogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosis. Exp Eye Res (2006) 0.83
Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus. Am J Ophthalmol (2009) 0.79
Provider use of collaborative goal setting with glaucoma patients. Optom Vis Sci (2014) 0.77
Scalable liquid shear-driven fabrication of polymer nanofibers. Adv Mater (2015) 0.77
Reply: To PMID 23791404. J AAPOS (2013) 0.75
Retinopathy of prematurity and transfusion practice. Transfusion (2014) 0.75
Diode laser for ROP. Ophthalmology (2005) 0.75
Communication Predicts Medication Self-Efficacy in Glaucoma Patients. Optom Vis Sci (2016) 0.75
Glaucoma patient expression of medication problems and nonadherence. Optom Vis Sci (2015) 0.75
Radial choroidal ruptures in sclopetaria. J Am Coll Surg (2003) 0.75